Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mylvaganam

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Annals of Internal Medicine|August 1, 1987
Low-dose danazol therapy in idiopathic thrombocytopenic purpuraY S Ahn, R Mylvaganam, R O Garcia, et al.
Hospital Practice (Office Ed.)|September 1, 1983
Treatment of idiopathic thrombocytopenic purpuraW J Harrington, Y S Ahn, J J Byrnes, et al.
The New England Journal of Medicine|June 9, 1983
Danazol for the treatment of idiopathic thrombocytopenic purpuraY S Ahn, W J Harrington, S R Simon, et al.
Blood|May 1, 1988
Depressed functional and phenotypic properties of T but not B lymphocytes in idiopathic thrombocytopenic purpuraR Mylvaganam, R O Garcia, Y S Ahn, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 1, 1989
Danazol therapy renders red cells resistant to osmotic lysisY S Ahn, L F Fernandez, C I Kim, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 13, 2012
The Your Disease Risk Index for colorectal cancer is an inaccurate risk stratification tool for advanced colorectal neoplasia at screening colonoscopyPaul C Schroy, Alison M Coe, Shamini R Mylvaganam, et al.
American Journal of Preventive Medicine|November 20, 2012
Aid-assisted decision making and colorectal cancer screening: a randomized controlled trialPaul C Schroy, Karen M Emmons, Ellen Peters, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Annals of Internal Medicine|August 1, 1987
Low-dose danazol therapy in idiopathic thrombocytopenic purpuraY S Ahn, R Mylvaganam, R O Garcia, et al.
Hospital Practice (Office Ed.)|September 1, 1983
Treatment of idiopathic thrombocytopenic purpuraW J Harrington, Y S Ahn, J J Byrnes, et al.
The New England Journal of Medicine|June 9, 1983
Danazol for the treatment of idiopathic thrombocytopenic purpuraY S Ahn, W J Harrington, S R Simon, et al.
Blood|May 1, 1988
Depressed functional and phenotypic properties of T but not B lymphocytes in idiopathic thrombocytopenic purpuraR Mylvaganam, R O Garcia, Y S Ahn, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 1, 1989
Danazol therapy renders red cells resistant to osmotic lysisY S Ahn, L F Fernandez, C I Kim, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 13, 2012
The Your Disease Risk Index for colorectal cancer is an inaccurate risk stratification tool for advanced colorectal neoplasia at screening colonoscopyPaul C Schroy, Alison M Coe, Shamini R Mylvaganam, et al.
American Journal of Preventive Medicine|November 20, 2012
Aid-assisted decision making and colorectal cancer screening: a randomized controlled trialPaul C Schroy, Karen M Emmons, Ellen Peters, et al.
Pageof 2